ImmunoBrain
Company

ImmunoBrain

Biotechnology Research New York, Ny, Il 19 employees
Employees
19
Contacts
1
Emails
1

ImmunoBrain Overview

Headquarters
New York, Ny, Il
Industry
Biotechnology Research
Employees
19
Founded
2015
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About ImmunoBrain

ImmunoBrain is a clinical stage biopharmaceutical company transforming the fight against neurodegeneration and aging by targeting the immune system, restoring brain immune communications and boosting natural repair mechanisms. ImmunoBrain’s lead program is a proprietary antibody targeting the inhibitory immune checkpoint pathway PD-1/PD-L1, to treat Alzheimer's disease. ImmunoBrain's novel approach for the treatment of neurodegeneration is based on years of innovative, cutting-edge scientific discoveries made in the lab of Prof. Michal Schwartz at the Weizmann Institute of Science.

ImmunoBrain Contact Details

People in AeroLeads
4
With contact data
1
Email contacts
1
25.0% coverage

ImmunoBrain Org Chart

Sample employees and titles
Name Title Contact
Sharona Raveh VP Manufacturing and Product
View
Avraham Kadar, M.d.
View
Sanjay Keswani CMO Neurocrine
View
Chana Sternberg Rn , Bsn, M.occ. H CEO & Founder @Csc - Clinical Trial
Email

Employees by Management Level

Executive 1 profile
VP / Head 1 profile
Individual contributor 1 profile

Compare Similar Companies to ImmunoBrain